Troy Bloom
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Growth Hormone and Insulin-like Growth Factors, Cancer Research and Treatments, Pancreatic and Hepatic Oncology Research, Cancer Cells and Metastasis
Most-Cited Works
- → Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies(2012)862 cited
- → Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer(2018)54 cited
- → Dual targeting of IGF-1R and ErbB3 as a potential therapeutic regimen for ovarian cancer(2019)22 cited
- → Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic(2020)18 cited
- → Use of KI67 and geminin expression to better define the proliferation status of invasive breast cancer.(2010)1 cited
- → Quantitative evaluation of HER2-mediated cellular uptake of the HER2-targeted antibody-liposomal doxorubicin conjugate MM-302 suggests potential for treating HER2-intermediate tumors(2016)1 cited
- → Figure S4 from Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer(2023)
- → Figure S5 from Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer(2023)
- → Figure S3 from Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer(2023)
- → Figure S6 from Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer(2023)